Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Evaluation of the Safety and Tolerability of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine in Individuals Aged 18 Years and Above: A Random PhaseⅡClinical Trial.

NCT07035054 is registered in ClinicalTrials.gov with Jiangsu Province Centers for Disease Control and Prevention as lead sponsor.

NCT NCT07035054
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07035054 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Evaluation of the Safety and Tolerability of 24-valent Pneumococcal Polysaccharide Conjugate Vaccine in Individuals Aged 18 Years and Above: A Random PhaseⅡClinical Trial.
Lead sponsor
Jiangsu Province Centers for Disease Control and Prevention
Phase
Phase 2
Overall status
Completed
Start date
April 20, 2024
Completion date
November 30, 2024
Enrollment
992 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

streptococcus pneumoniae pneumonia